
Investment firm backing cannabinoid businesses and publishing research on cannabis consumer markets

Early-stage venture investor focused on Series A rounds in consumer technology and infrastructure technology

N5Capital is a venture capital institution founded in 2013. It puts most of its effort into Series A investment, looking for young companies with strong technology and a route to becoming market leaders in their fields.
The firm has built a portfolio of more than 80 companies. Their business reaches mainland China and cross-border global markets. It operates as a dual-currency institution.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
N5Capital is ranked on 2 TrustList rankings: #8 on 1 and #34 on 1.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. N5Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is one of 2 here listing early stage and one of 4 here listing series a.
Its profile: “Their business reaches mainland China and cross-border global markets.”
Of the 27 here, 8 also cover partners and 6 also cover series; 9 also work in Shanghai and 7 also work in Beijing.
Behind Playfair Capital, ahead of InnoVen Capital.
It is one of 28 here listing series.
Its profile: “It puts most of its effort into Series A investment, looking for young companies with strong technology and a route to becoming market leaders in their fields.”
Of the top 57 here, 21 also cover seed stage and 16 also cover pre seed; 5 also work in Silicon Valley and 5 also work in London.
Behind VECTR Ventures, ahead of Monogram Capital Partners.
As of 2026-10-30. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about N5Capital.
Similar listings buyers compare against this one.

Investment firm backing cannabinoid businesses and publishing research on cannabis consumer markets

Technology investor with separate arms for growth companies, venture funds and sport

A global venture firm investing in sports and health technology startups through funds and advisory

European early-stage fund investing only in B2B software companies

Constantia New Business is a Vienna-based evergreen investor backing technology start-ups without exit pressure

Early-stage investor backing diverse founders in consumer experiences and the technologies behind them
Everything here links back to the same verified catalogue. Pick your next stop.